FDA Advisory Panel Deals Blow to Phillip Morris International’s iQOS Device
Phillips Morris International, Inc. was dealt a slight blow on Thursday when a group of U.S. health advisers offered the opinion that the big...
British American Tobacco Releases 2018 Harm Reduction Focus Report
Harm reduction has been a major initiative and focus of British American Tobacco (BAT) in recent years and 2018 was no different. With the...
FDA Grants Modified Risk Authorization to 22nd Century Group’s VLN
22nd Century Group, Inc., a leading agricultural biotechnology company that is focused on tobacco harm reduction and reduced nicotine tobacco products, has announced that...
FDA Authorizes Philip Morris USA to Sell IQOS in U.S.
Altria Group, Inc. has revealed that it has received authorization from the U.S. Food and Drug Administration (FDA) to sell its heat-not-burn device, IQOS,...
Is the FDA on the Brink of True Harm Reduction?
In July, the FDA announced a new regulatory plan to focus on reducing nicotine levels in cigarettes, with the purpose of reducing cigarette addiction....
Philip Morris International’s Revenue and Stock Jumps Due to IQOS
Philip Morris International (PMI) can thank the emerging market of heat-not-burn for not only meeting but beating recent revenue estimates.
Earlier this year, the U.S....